Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Pharmaceuticals & Biotech
Create a narrative
West Pharmaceutical Services Community
NYSE:WST Community
1
Narratives
written by author
0
Comments
on narratives written by author
18
Fair Values set
on narratives written by author
Community Investing Ideas
West Pharmaceutical Services
Popular
Undervalued
Overvalued
West Pharmaceutical Services
AN
AnalystConsensusTarget
Consensus Narrative from 11 Analysts
HVP Automation And GLP-1 Demand Will Strengthen Future Position
Key Takeaways Growth in GLP-1s and HVP components could drive significant revenue and earnings growth through favorable market opportunities and mix shifts. Strategic expansion into drug handling and automated deliveries is expected to enhance margins through operational efficiencies and higher-margin contracts.
View narrative
US$316.36
FV
21.9% undervalued
intrinsic discount
6.52%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
7
users have followed this narrative
6 days ago
author updated this narrative
Your Valuation for
WST
WST
West Pharmaceutical Services
Your Fair Value
US$
Current Price
US$246.99
0.7% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
4b
2015
2018
2021
2024
2025
2027
2030
Revenue US$4.0b
Earnings US$660.5m
Advanced
Set Fair Value